We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+6.17%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+557.96%
AUM
$144B
AUM Growth
+$27.9B
Cap. Flow
+$22.2B
Cap. Flow %
15.4%
Top 10 Hldgs %
31.02%
Holding
7,740
New
680
Increased
3,884
Reduced
2,259
Closed
408

Sector Composition

Rank Sector Weight
1 Technology 8.24%
2 Financials 5.68%
3 Healthcare 5.62%
4 Consumer Discretionary 5.04%
5 Industrials 3.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IPGP icon
4751
PUT
IPG Photonics
IPGP
$3.57B
$250K ﹤0.01%
1,600
+1,100
+220% +$204K
SENEA icon
4752
Seneca Foods Class A
SENEA
$1.31B
$250K ﹤0.01%
7,416
+4,931
+198% +$148K
QEP
4753
CALL
DELISTED
QEP RESOURCES, INC.
QEP
$250K ﹤0.01%
22,100
-6,000
-21% -$64.7K
LPX icon
4754
CALL
Louisiana-Pacific
LPX
$5.18B
$249K ﹤0.01%
9,400
-145,200
-94% -$4.14M
IBA
4755
DELISTED
Industrias Bachoco SAB De C.V.
IBA
$249K ﹤0.01%
+4,600
New +$268K
FLXN
4756
DELISTED
Flexion Therapeutics, Inc.
FLXN
$248K ﹤0.01%
13,249
+10,789
+439% +$248K
AFMD
4757
DELISTED
Affimed
AFMD
$247K ﹤0.01%
5,676
+4,337
+324% +$123K
VCYT icon
4758
Veracyte
VCYT
$3.42B
$247K ﹤0.01%
25,840
+23,162
+865% +$255K
RACE icon
4759
PUT
Ferrari
RACE
$72.5B
$246K ﹤0.01%
1,800
+500
+38% +$65.8K
SNN icon
4760
Smith & Nephew
SNN
$12.6B
$245K ﹤0.01%
6,600
+5,600
+560% +$202K
MED icon
4761
CALL
Medifast
MED
$128M
$244K ﹤0.01%
1,100
-2,100
-66% -$426K
OXM icon
4762
PUT
Oxford Industries
OXM
$542M
$244K ﹤0.01%
2,700
-100
-4% -$9.1K
QVCGA
4763
PUT
DELISTED
QVC Group Inc Series A
QVCGA
$244K ﹤0.01%
227
-57
-20% -$59.9K
LEAF
4764
DELISTED
Leaf Group Ltd.
LEAF
$244K ﹤0.01%
24,403
+22,325
+1,074% +$242K
UCFC
4765
DELISTED
United Community Financial Corp
UCFC
$244K ﹤0.01%
25,231
+21,681
+611% +$228K
MZOR
4766
DELISTED
Mazor Robotics Ltd.
MZOR
$244K ﹤0.01%
+4,187
New +$223K
RESI
4767
DELISTED
Front Yard Residential Corporation Common Stock
RESI
$243K ﹤0.01%
22,379
+18,769
+520% +$209K
BMRC icon
4768
Bank of Marin Bancorp
BMRC
$462M
$242K ﹤0.01%
5,770
+4,774
+479% +$206K
EHC icon
4769
CALL
Encompass Health
EHC
$12.2B
$242K ﹤0.01%
+3,897
New +$237K
RMD icon
4770
PUT
ResMed
RMD
$32.9B
$242K ﹤0.01%
2,100
+1,300
+163% +$142K
BPT
4771
PUT
DELISTED
BP Prudhoe Bay Royalty Trust
BPT
$241K ﹤0.01%
7,000
+4,700
+204% +$141K
HIO
4772
Western Asset High Income Opportunity Fund
HIO
$338M
$241K ﹤0.01%
50,590
LXRX icon
4773
Lexicon Pharmaceuticals
LXRX
$1.04B
$241K ﹤0.01%
22,649
+19,485
+616% +$223K
PGC icon
4774
Peapack-Gladstone Financial
PGC
$822M
$241K ﹤0.01%
7,797
+6,455
+481% +$215K
SOGO
4775
CALL
DELISTED
Sogou Inc. American Depositary Shares, each representing one Class A Ordinary Share
SOGO
$241K ﹤0.01%
32,500
+8,700
+37% +$79.7K

Similar funds

Barclays's Q3 2018 Portfolio in Review

As of Q3 2018, Barclays held 7,740 positions worth $144B, up 24% from $116B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Barclays deployed $22.2B of net new capital in Q3 2018, opening 680 new positions and adding to 3,884 existing holdings. Its largest new stake was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.

By sector, the portfolio is most concentrated in Technology at 8.2% of assets, up from 7.4% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Weyerhaeuser, an estimated $431M trimmed.

  • Barclays's largest Q3 2018 buy was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
  • Barclays added most to Fortive in Q3 2018, an estimated $1.27B increase.
  • Barclays's biggest Q3 2018 reduction was Weyerhaeuser, cutting an estimated $431M.
  • Barclays fully exited Validus Hold Ltd in Q3 2018, selling an estimated $71M.
  • Barclays's ten largest holdings make up 31% of its $144B portfolio in Q3 2018.
  • Barclays opened 680 new positions and closed 408 in Q3 2018.
  • Barclays's portfolio value rose 24% quarter-over-quarter to $144B.

Based on Barclays's 13F filing for Q3 2018, filed 14 Nov 2018.